Belgium vs Qatar: The number of people with susceptibility test result for rifampicin
Belgium
377
in 2021
Qatar
411
in 2021
Belgium rank
86th
Qatar rank
84th
The number of people with susceptibility test result for rifampicin over time
- Belgium
- Qatar
How they compare
Qatar currently reports 411 against 377 in Belgium, a difference of 34.
That makes Qatar's figure about 1.1 times Belgium's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Belgium ahead.
Belgium ranks 86th and Qatar ranks 84th of 155 countries.
Across the 2 decades both report, Belgium averaged higher in 1 and Qatar in 1.
Head to head by decade
| Decade | Belgium | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 430 | 297.67 | 132.33 | Belgium |
| 2020s | 348.5 | 392.5 | 44 | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Belgium or Qatar?
- Qatar, at 411 against 377 in Belgium as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Belgium and Qatar?
- 34, with Qatar ahead.
- How many years of comparable data are there for Belgium and Qatar?
- 5 years are reported by both, from 2017 to 2021.
- How do Belgium and Qatar rank globally for the number of people with susceptibility test result for rifampicin?
- Belgium ranks 86th and Qatar ranks 84th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.